- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02130921
Enhancing the Role of Commune Health Workers in HIV and Drug Control: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Vietnam is currently facing an HIV epidemic that had affected approximately 280,000 people by the end of 2009. Injecting Drug Use (IDU) is principal driver of the HIV epidemic, contributing to between 32 % and 58 % of all HIV cases in various provinces. However, it has proven difficult to address the needs of IDUs, a high-risk group, given the prevalence of stigmatization and drug use in Vietnamese society. In addition, Vietnamese people are highly family oriented and most young IDUs have daily family contact of live in their parents' homes. Thus the burden on the family is substantial, and even greater if the IDU is HIV+.
The study will be implemented in two provinces in Vietnam: Phu Tho and Vinh Phuc. A randomized controlled trial will be conducted to evaluate the impact of the intervention in 60 commune health centers. From each center we will recruit 5 Community Health Workers (CHWs), 15 Injecting Drug Users (IDUs), and 10 Family Members (FMs) (totaling 300 CHWs, 900 IDUs, and 600 FMs). The outcomes will be evaluated at 3-, 6-, 9-, and 12- month follow-up assessments. The specific aims of the study are as follows:
- To develop and implement an integrated intervention, CHW CARE, for CHWs, IDUs, and their FMS in Vietnam
- To evaluate the feasibility and operational procedures of the intervention with an implementation pilot, including process evalution and monitoring, and participants feedback.
- To assess the impact of the intervention by comparing outcome measures of CHWs, IDUs, and FMs in the intervention group to those in the control group.
- To explore the relationships between the intervention outcomes of CHWs, IDUs, and FMs.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Phú Thọ, Vietnam
- Phú Thọ commune health centers
-
Vĩnh Phúc, Vietnam
- Vĩnh Phúc commune health centers
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Injecting Drug Users:
- Age 18 or over
- Having a history of drug use
- Currently residing in the selected commune, and have no plan to move to other communes in the following year
- Voluntary informed consent
Family members of Injecting Drug Users:
- Age 18 or over
- Immediate or extended family member of the Injecting Drug User.
- Previous knowledge of the drug use of the IDU.
- Voluntary informed consent
- Currently residing in the selected commune, and have no plan to move to other communes in the following year
Community Health Workers:
- Age 18 or over
- Doctor, nurse, or other care provider working at the selected commune health centers
- Informed consent
Exclusion Criteria:
Injecting Drug Users:
- Those who have psychosis or neurological damage, or cannot understand the study purposes as judged by the interviewer in consultation with a clinic supervisor, will be excluded
- Does not meet other inclusion criteria
Family members of Injecting Drug Users:
- Those who have psychosis or neurological damage, or cannot understand the study purposes as judged by the interviewer in consultation with a clinic supervisor, will be excluded
- Does not meet other inclusion criteria
Community Health Workers:
- Inability to give informed consent
- Does not meet other inclusion criteria
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
NO_INTERVENTION: Control
Community Health Workers (CHWs) in the control group will be invited to one group lecture didactically reviewing medical ethics, and the attending CHWs will be requested to pay a home visit to participating IDUs and FMs after the lecture.
|
|
EXPERIMENTAL: Intervention
Intervention for CHWs: 3 sessions will cover the understanding stigma and its impact, self-protection and universal precaution adherence, effective communication with patients and family members, and motivational enhancement for behavioral change. Intervention for IDUs: CHWs who participate in the intervention will be required to conduct 3 individual sessions with participating IDUs covering the following topics: physical health, risk reduction behaviors, mental health, and community integration. Intervention for FMs: CHWs who participate in the intervention will be required to conduct 2 group sessions with participating FMs covering the following topics: healthy family routine, coping with caregiver burdens, enhance family relationships, support positive behavior change. |
Intervention for CHWs: 3 sessions will cover the understanding stigma and its impact, self-protection and universal precaution adherence, effective communication with patients and family members, and motivational enhancement for behavioral change. Intervention for IDUs: CHWs who participate in the intervention will be required to conduct 3 individual sessions with participating IDUs covering the following topics: physical health, risk reduction behaviors, mental health, and community integration. Intervention for FMs: CHWs who participate in the intervention will be required to conduct 2 group sessions with participating FMs covering the following topics: healthy family routine, coping with caregiver burdens, enhance family relationships, support positive behavior change. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Community Health Worker (CHW) Interaction with patients
Time Frame: Changes from baseline to 3-, 6-, 9- and 12- month follow-up
|
Provider-Client interaction scale will be used.
|
Changes from baseline to 3-, 6-, 9- and 12- month follow-up
|
Injecting Drug User (IDU) drug use
Time Frame: baseline, 3-, 6-, 9- and 12- month follow-up
|
Urine test results
|
baseline, 3-, 6-, 9- and 12- month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Community Health Worker (CHW) job safety, support, and satisfaction
Time Frame: Changes from baseline to 3-, 6-, 9-, and 12- month follow-up
|
This will be assessed by perceived risk at work and institutional support.
Additionally by job satisfaction using a 29-item scale.
|
Changes from baseline to 3-, 6-, 9-, and 12- month follow-up
|
Community Health Worker (CHW) knowledge and adherence to universal precautions
Time Frame: Changes from baseline to 3-, 6-, 9-, and 12- month follow-up
|
This will be assessed with the universal precautions knowledge scale.
|
Changes from baseline to 3-, 6-, 9-, and 12- month follow-up
|
Injecting Drug User (IDU) family and social support
Time Frame: Changes from baseline to 3-, 6-, 9- and 12- month follow-up
|
This is measured by two instruments.
Social Support Questionnaire (Short; SSQ6) is a 6-item assessment to measure satisfaction of social support.
Number of social support providers is captured up to 9 people in various support dimensions (Sarason et al., 1983).
Medical Outcomes Study- Social Support Scale (MOS-SS) is a 20-item scale that measures the strength of perceived social support available.
The scale consists of five dimensions: emotional support, informational support, tangible support, positive social interaction, and affection
|
Changes from baseline to 3-, 6-, 9- and 12- month follow-up
|
Family Member (FM) social support
Time Frame: Changes from baseline to 3-, 6-, 9-, and 12- month follow-up
|
This is measured by two instruments.
Social Support Questionnaire (Short; SSQ6) is a 6-item assessment to measure satisfaction of social support.
Number of social support providers is captured up to 9 people in various support dimensions (Sarason et al., 1983).
Medical Outcomes Study- Social Support Scale (MOS-SS) is a 20-item scale that measures the strength of perceived social support available.
The scale consists of five dimensions: emotional support, informational support, tangible support, positive social interaction, and affection.
|
Changes from baseline to 3-, 6-, 9-, and 12- month follow-up
|
Community Health Worker (CHW) general prejudicial attitude
Time Frame: Changes from baseline to 3-, 6-, 9- and 12- month follow-up
|
A scale will be used
|
Changes from baseline to 3-, 6-, 9- and 12- month follow-up
|
Family Member (FM) Caregiver burden/coping
Time Frame: Changes from baseline to 3-,6-,9-, and 12-month follow-up
|
Caregiver burden and coping scales will be used
|
Changes from baseline to 3-,6-,9-, and 12-month follow-up
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01DA033609-01 (NIH)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Drug Dependence
-
Universidad de AntioquiaCompletedControlled Drug DependenceColombia
-
Rajmonda Nallbani-KomoniUnknownAnalgesic Drug DependenceKosovo
-
University of South FloridaRecruitingColectomy | Analgesic Drug DependenceUnited States
-
Indivior Inc.CompletedOpioid-Related Disorders | Drug Abuse | Opiate DependenceAustria
-
Massachusetts General HospitalCompletedAlcohol Dependence | Drug Abuse | Alcohol Abuse | Drug DependenceUnited States
-
International Center for Ethnobotanical Education...University of Sao Paulo; Universidad Autonoma de Madrid; University Rovira i... and other collaboratorsRecruitingOpioid Dependence | Drug Dependence | Drug Use DisordersSpain
-
Boston Medical CenterBoston University; National Institute on Drug Abuse (NIDA); RTI InternationalCompletedDrug Abuse | Drug Usage | Drug DependenceUnited States
-
University of California, Los AngelesCompleted
-
Nantes University HospitalCompletedDrug Abuse | Drug DependenceFrance
-
St. Olavs HospitalRecruitingSubstance-Related Disorders | Drug Abuse | Drug DependenceNorway
Clinical Trials on Intervention to Address Drug Use and HIV in Vietnam
-
University of California, Los AngelesNational Institute of Hygiene and Epidemiology, VietnamCompleted
-
University of Massachusetts, WorcesterNational Cancer Institute (NCI); Institute of Population, Health and Development...Enrolling by invitationTobacco CessationVietnam, United States
-
Brigham and Women's HospitalNational Institute on Aging (NIA)Enrolling by invitationAddressing Diffusion of Responsibility and Prescribing Burden to Improve Use of Diabetes MedicationsDiabetes | SGLT-2i and GLP-1RA Therapies | Diffusion of Responsibility | Prescribing BurdenUnited States
-
Wayne State UniversityCompleted
-
University of TorontoGeorgetown University; Children's Hospital Medical Center, Cincinnati; University... and other collaboratorsRecruitingLanguage Development | Developmental Language Disorder | Language DelayCanada
-
RTI InternationalFogarty International Center of the National Institute of Health; Muhimbili...CompletedDrug Use Stigma in HIV Treatment ClinicsTanzania
-
Hunter College of City University of New YorkCompletedSubstance Use | Sexual RiskUnited States
-
University College, LondonUnknownInflammatory Bowel Disease (IBD)
-
Sanaullah IqbalUniversity of the PunjabCompletedChild Nutrition DisordersPakistan
-
Northwestern UniversityUniversity of Illinois at ChicagoCompletedDiabetes Mellitus Type II | Diabetes Mellitus Type IUnited States